Dmitry Balyasny’s Terns Pharmaceuticals TERN Stock Holding History

Dmitry Balyasny’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,108,000	Closed	-$58.4M	–	3488
2026 Q1	$58.4M	Buy	+1,108,000	New	+$45.5M	0.08%	299

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Dmitry Balyasny's TERN Position: Q2 2026 in Review

Dmitry Balyasny sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 2,779,445 shares — an estimated $147M sold.

Dmitry Balyasny first reported a position in TERN in Q2 2021 and held it in 8 quarters. The position peaked at $147M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Dmitry Balyasny reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Dmitry Balyasny sold 2,779,445 Terns Pharmaceuticals shares in Q2 2026, an estimated $147M.
Dmitry Balyasny first reported a position in Terns Pharmaceuticals in Q2 2021 and held it in 8 quarters.
Dmitry Balyasny's Terns Pharmaceuticals position peaked at $147M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.